ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: TH-PO323

Machine Learning for Identification of Near-Term All-Cause and Cardiovascular Death Among Patients Undergoing Peritoneal Dialysis

Session Information

  • Home Dialysis - I
    November 02, 2023 | Location: Exhibit Hall, Pennsylvania Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Dialysis

  • 802 Dialysis: Home Dialysis and Peritoneal Dialysis


  • Xu, Xiao, Peking University First Hospital Department of Nephrology, Beijing, Beijing, China
  • Dong, Jie, Peking University First Hospital Department of Nephrology, Beijing, Beijing, China

Although more and more cardiovascular risk factors have been verified in peritoneal dialysis (PD) populations in different countries and regions, it is still difficult for clinicians to accurately predict who will have cardiovascular events and when the cardiovascular events will occur and cause death. We developed and validated machine learning-based models to predict near-term all-cause and cardiovascular death.


Machine learning models were developed on the Peritoneal Dialysis Telemedicine-assisted Platform Cohort (PDTAP) of 7539 PD patients enrolled between June 2016 and April 2019, which was randomly divided into a training set and an internal test set by 5 random shuffles of 5-fold cross-validation, to predict of 3-month cardiovascular death and all-cause death. We chose objectively collected markers such as patient demographics, clinical characteristics, and laboratory, and dialysis-related variables to inform the models and assessed the predictive performance using a range of common performance metrics, such as precision, accuracy, and area under the curve (AUC).


CVDformer model was used to predict 3-month cardiovascular death of PD patients. In the test set, CVDformer model had a precision of 87.96% - 89.45% and an accuracy of 86.10% - 88.74%. best than the LSTM model had 78.78% - 80.45% for precision and 76.53% - 79.12% for accuracy. The AUC was 0.88-0.90 in identifying the presence of near-term all-cause death and cardiovascular death using the CVDformer model.


We developed and used a novel combination of machine learning methods to assess the all-cause mortality risk and cardiovascular death risk in 3 months. The ability to identify the potential risks of all-cause and cardiovascular death with an inexpensive, widely available, and automatic procedure has important practical implications, particularly for the management of dialysis patients.